Status: Strategy hypotheses; no commercial model approved
Last reviewed: 2026-07-30
Exhibit is public and MIT-licensed as of 2026-07-31, but not yet submitted to the Chrome Web Store. There is no approved price, billing system, sales motion, public support channel, legal owner identity, or Chrome Web Store publisher account in this repository.
This means Exhibit is currently an engineering asset, not a sellable product.
| Role | Problem | Value sought | Likely buying role |
|---|---|---|---|
| Frontend developer | Server Actions and RSC are opaque in the Network panel | Framework-aware explanation from browser evidence | Self-serve user |
| QA engineer | Reproduction lacks technical evidence | Faster, safer handoff | QA lead or engineering manager |
| Support engineer | Customer report cannot explain browser behavior | Escalation package engineering can use | Support operations lead |
| Security-conscious organization | Debug evidence may contain credentials | Local processing, strict redaction, controlled deployment | Security/IT plus engineering |
Recommended first segment: frontend developers working on authorized Next.js applications. This remains a hypothesis until interviews and usage tests support it.
The segment is deliberately the one with the weakest buying authority, because at this stage the constraint is adoption, not revenue. Frontend developers install DevTools extensions without procurement; QA, support, and security buyers are reached later, through teams that already run it. See PRODUCT.md for the full wedge rationale.
Exhibit competes first with “free and already open”: Chrome DevTools. Mature tools then add broader interception, screen recording, collaboration, integrations, or traffic modification. A price cannot be justified by capture, filtering, timing, cURL, or sanitized HAR alone.
Willingness to pay must come from measurable savings in:
Risks that can erase that value:
Keep the local extension free. Charge organizations for managed deployment, compatibility commitments, priority support, security review material, and training.
Advantages: Preserves no-account promise; low adoption friction; aligns revenue with organizational needs.
Costs: Support revenue is service-heavy; individual use does not monetize; requires a clear commercial licence and support capacity.
Sell individual or organization licences while keeping capture fully local. Billing and entitlement must be designed without quietly adding product telemetry.
Advantages: Direct value capture; simple product story.
Costs: Competes with free DevTools; account/licence enforcement can conflict with local-only positioning; billing, entitlement, tax/VAT, terms, order, refund, chargeback, and support operations become mandatory.
Open the evidence engine and local extension; sell organization deployment, policy controls, support, and any future collaboration layer.
Advantages: Trust and adoption; community protocol coverage; inspectable privacy claims.
Costs: Requires governance and contribution capacity; differentiation must extend beyond source availability; dual-licensing needs legal work.
Do not choose paid packaging before validating the wedge.
| Package | Candidate scope | Evidence needed before approval |
|---|---|---|
| Local | Current Chrome extension, local evidence, exports | First-time success and recurring use |
| Organization | Local package plus deployment guide, support, compatibility policy, security material | At least three teams request these needs |
| Future team workflow | Controlled sharing/collaboration | Repeated evidence that sanitized file handoff is insufficient |
Cloud collaboration remains outside version 0.1. It must not be added merely to copy Jam or Requestly; it needs an evidence-backed user problem and a new privacy design.
Candidate channels:
Avoid claims that Exhibit replaces Chrome Network, sees server behavior, or is the first privacy-safe debugger.
The current product has no runtime backend cost. Business costs still include:
Future cloud, billing, or collaboration features would materially change the cost and privacy model.
No public distribution or commercial sale until all gates pass:
The repository cannot determine these: